09:37 AM EST - DRI Healthcare Trust : Announced that a wholly-owned subsidiary of DRI has acquired a royalty interest in pegcetacoplan for an upfront purchase price of $24.5 million U.S., with an option to increase its interest in pegcetacoplan in the future. DRI Healthcare Trust
shares T.DHT.UN are trading unchanged at $9.01.
